SRSF2

Serine/arginine-rich splicing factor 2 · Q01130 · SRSF2 on Sugi Atlas →

0 patent compounds predicted against SRSF2, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to SRSF2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Valproate and Levocarnitine in Children With Spinal Muscular Atrophy PHASE3UNKNOWN
Anastrozole or Fulvestrant in Treating Postmenopausal Patients With Breast Cancer PHASE2COMPLETED
A Phase 2 Trial of SCO-101 in Combination With FOLFIRI for Patients With Metastatic Colorectal Cancer (mCRC) With Acquired Resistance to FOLFIRI PHASE1/PHASE2UNKNOWN
SRSF2 Gene Mutation in Patients With t-MDS/AML nanCOMPLETED
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Patient's Derived Organoids for Drug Screening in Glioblastoma nanNOT_YET_RECRUITING
Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs nanUNKNOWN
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
Becker Muscular Dystrophy - A Natural History Study to Predict Efficacy of Exon Skipping nanUNKNOWN
Personalized Medicine Program on Myelodysplastic Syndromes: Characterization of the Patient's Genome for Clinical Decision Making and Systematic Collection of Real World Data to Improve Quality of Health Care nanCOMPLETED
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact nanUNKNOWN
Transcriptomes Breast, Ovarian and Leukocyte Hereditary Genes Predisposing to Breast and / or Ovarian Cancer nanCOMPLETED
Biocollection in MyeloDysplastic Syndrome (P-MDS) nanRECRUITING
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
MicroRNA-1 (miRNA-1) and MicroRNA-133a (miRNA-133a) Levels After Acute Exercise in Ultimate Frisbee Athletes nanUNKNOWN
Transcriptomic Profile of Patients Treated With Different Modalities of Spinal Cord Stimulation nanUNKNOWN
Clinical and Genomic Registry of MDS in Asia nanUNKNOWN
Research for Individualized Therapeutics in Rare Genetic Disease nanENROLLING_BY_INVITATION
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
Clinical Study of Spinal Muscular Atrophy nanCOMPLETED
Prospective Study of Molecular Predictors of Survival in Myelodysplastic Syndromes nanCOMPLETED
Molecular Disease Profile of Hematological Malignancies nanUNKNOWN
Efficacy and Safety Study of EGCG/Tocotrienol in 18 Patients With Splicing-mutation-mediated Cystic Fibrosis (CF) nanCOMPLETED
Mechanisms of Cell Death in Spinal Muscular Atrophy nanCOMPLETED
Identification and Characterization of Novel Non-Coding Variants That Contribute to Genetic Disorders nanCOMPLETED
Immunophenotyping and Xist Gene in AML nanUNKNOWN
RNA Sequencing in the Framingham Heart Study Third Generation Cohort Exam 2 nanCOMPLETED
Thermogenic Silencer Regulatory Factors in Humans nanACTIVE_NOT_RECRUITING
Circulating Biomarker Signatures for the Detection of Gastric Preneoplasia and Cancer nanRECRUITING
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a SRSF2 binder may also engage these)

ProteinNameSimilarity
Q6PDU1 1.000 Q6PDU1 →
Q62093 1.000 Q62093 →
Q3MHR5 1.000 Q3MHR5 →
Q5R1W5 1.000 Q5R1W5 →
Q06A98 1.000 Q06A98 →
P30352 1.000 P30352 →
Q09511 0.996 Q09511 →
A2RVS6 0.995 A2RVS6 →
O22315 0.994 O22315 →
Q9LHP2 0.994 Q9LHP2 →
Q9BRL6 0.991 Q9BRL6 →
Q9SEU4 0.991 Q9SEU4 →
Q1PDV2 0.990 Q1PDV2 →
Q13595 0.990 Q13595 →
Q9FYB7 0.990 Q9FYB7 →
P62996 0.990 P62996 →
TRA2B Transformer-2 protein homolog beta 0.990 landscape →
P92966 0.990 P92966 →
Q9V3V0 0.989 Q9V3V0 →
Q9FMG4 0.989 Q9FMG4 →
P62997 0.989 P62997 →
Q3ZBT6 0.989 Q3ZBT6 →
Q6PFR5 0.988 Q6PFR5 →
O75494 0.988 O75494 →
Q3T106 0.987 Q3T106 →
Q84TH4 0.987 Q84TH4 →
SRSF7 Serine/arginine-rich splicing factor 7 0.987 landscape →
Q8L3X8 0.987 Q8L3X8 →
Q9R0U0 0.987 Q9R0U0 →
Q18409 0.987 Q18409 →